New receptor ‘decoy’ drug neutralizes COVID-19 virus and its variants

Cloud technology with futuristic hologram on smartwatch

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant. The drug is designed in such a way that natural selection to maintain infectiousness of the virus should also maintain the drug’s activity against future variants.

Some forms of childhood malnutrition and growth stunting may be preventable with vaccines

Previous article

Study examines hesitation toward potential changes to bowel cancer surveillance

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations